Elephas has developed an ex-vivo platform to assess how live patient biopsies respond to immunotherapies. By preserving the native tumor microenvironment from a live core needle biopsy and using a novel method to address tumor heterogeneity, the elive platform enables a real-time characterization of immune response. To learn more, visit www.elephas.com
| Website | https://elephas.com/ |
| Revenue | $14.8 million |
| Employees | 154 (105 on RocketReach) |
| Founded | 2020 |
| Industry | Medical and Diagnostic Laboratories |
| Keywords | Cancer Immunotherapy, Oncology Platform, Tumor Microenvironment, Precision Oncology, Immunotherapy Development, Cancer Diagnostics, Biotechnology Platform, Drug Development, Healthcare Technology, Oncology Technology, Cancer Treatment, Personalized Medicine, Medical Technology, Data Driven Healthcare |
| Competitors | Jasper (Formerly Jarvis), Writesonic, Copy.ai, Zyro, Frase, Rytr, ContentBot.ai, Headlime, Wordtune +32 more (view full list) |
Looking for a particular Elephas employee's phone or email?
The Elephas annual revenue was $14.8 million in 2026.
Maneesh Arora is the CEO of Elephas.
105 people are employed at Elephas.
Elephas is based in Madison, Wisconsin.